APA (7th ed.) Citation

Fan, W., Zhu, B., Yue, S., Zheng, X., Zou, X., Li, F., . . . Li, J. (2023). Idarubicin‐Loaded DEB‐TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score‐matching analysis. Cancer Medicine, 12(1), 61. https://doi.org/10.1002/cam4.4937

Chicago Style (17th ed.) Citation

Fan, Wenzhe, et al. "Idarubicin‐Loaded DEB‐TACE Plus Lenvatinib Versus Lenvatinib for Patients with Advanced Hepatocellular Carcinoma: A Propensity Score‐matching Analysis." Cancer Medicine 12, no. 1 (2023): 61. https://doi.org/10.1002/cam4.4937.

MLA (9th ed.) Citation

Fan, Wenzhe, et al. "Idarubicin‐Loaded DEB‐TACE Plus Lenvatinib Versus Lenvatinib for Patients with Advanced Hepatocellular Carcinoma: A Propensity Score‐matching Analysis." Cancer Medicine, vol. 12, no. 1, 2023, p. 61, https://doi.org/10.1002/cam4.4937.